FSD Pharma (STU:0K9) Accounts Payable & Accrued Expense : €3.03 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is FSD Pharma Accounts Payable & Accrued Expense?

FSD Pharma's quarterly accounts payable & accrued expense increased from Sep. 2023 (€3.47 Mil) to Dec. 2023 (€3.85 Mil) but then declined from Dec. 2023 (€3.85 Mil) to Mar. 2024 (€3.03 Mil).

FSD Pharma's annual accounts payable & accrued expense increased from Dec. 2021 (€6.61 Mil) to Dec. 2022 (€6.71 Mil) but then declined from Dec. 2022 (€6.71 Mil) to Dec. 2023 (€3.85 Mil).

FSD Pharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for FSD Pharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FSD Pharma Accounts Payable & Accrued Expense Chart

FSD Pharma Annual Data

Trend

Aug15

Aug16

Aug17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3.03

2.90

6.61

6.71

3.85

FSD Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															7.20	4.91	3.47	3.85	3.03

FSD Pharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

FSD Pharma (STU:0K9) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FSD Pharma Inc (STU:0K9) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

HUGE:USA 0K9:Germany HUGE:Canada

Address

199 Bay Street, Suite 4000, Toronto, ON, CAN, M5L 1A9

Website

https://www.fsdpharma.com

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The Company operates in two segments: Biotechnology and Strategic Investments.

FSD Pharma (STU:0K9) Headlines

No Headlines